Výsledky vyhledávání - "Joshua Veatch"

Akademický článek

768 Transcriptional profiling of Merkel cell carcinoma that escaped polyomavirus-specific TCR-engineered T cells reveals actionable immunotherapy approaches

Autor: Philip D Greenberg, Aude Chapuis, Paul Nghiem, Valentin Voillet, Cecilia CS Yeung, Brandon Seaton, Joshua Veatch, Thomas M Schmitt, Yuta Asano, Bo Lee, Lauren Martin, Jakob Bakhtiari

Publikováno v: Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)

Externí odkaz: https://doaj.org/article/1a7b754e833843e284e2f6dd3c0a4284

Zobrazit plný text záznamu

Akademický článek

819 Concurrent treatment with GM-CSF immunoembolization of hepatic metastases and systemic immune checkpoint inhibitors to overcome immune evasion in patients with metastatic uveal melanoma

Autor: Evan Hall, Shailender Bhatia, Joshua Veatch, Wayne Monsky, Natalie J Miller, Jacob Leary, William McCamy

Publikováno v: Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)

Externí odkaz: https://doaj.org/article/eec190efbfad45b3ac51a9fac1981070

Zobrazit plný text záznamu

Akademický článek

661 Neoantigen-specific CD4+ T cells in human melanoma have diverse differentiation states and correlate with CD8+ T cell, macrophage, and B cell function

Autor: Evan Hall, Stanley Riddell, Sylvia Lee, David Byrd, Shailender Bhatia, Scott Tykodi, Raphael Gottardo, Naina Singhi, Ata Moshiri, Evan Newell, Carolyn Shasha, Julia Szeto, Teresa Kim, Venu Pillarisetty, Kimberly Smythe, Joshua Veatch

Publikováno v: Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)

Externí odkaz: https://doaj.org/article/7e1cc514633a4cdb819c2b471745a17b

Zobrazit plný text záznamu

ATTAC-MCC: Phase I/II study of autologous CD8+ and CD4+ transgenic T cells expressing a high affinity MCPyV-specific TCR combined with checkpoint inhibitors and class I MHC-upregulation in patients with metastatic MCC refractory to PD-1 axis blockade

Autor: Joshua Veatch, Ananth Akkiraju, Agus Darwanto, Sean Garrity, Damien Hallet, Kim Nguyen, Piotr Pierog, Tomasz Sewastianik, Markus P Vallaster, Loic Vincent, Aude Chapuis

Publikováno v: Journal of Clinical Oncology. 40:TPS9596-TPS9596

TPS9596 Background: Merkel cell carcinoma (MCC) is a highly aggressive skin cancer, with an incidence that has doubled in the last 20 years to approximately 3000 cases/year in the US. Over one-third of patients will develop widespread disease, and su

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ed76729b012f42f3686f334ed6fb7dce
https://doi.org/10.1200/jco.2022.40.16_suppl.tps9596

Zobrazit plný text záznamu

Merkel polyoma virus specific T-cell receptor transgenic T-cell therapy in PD-1 inhibitor refractory Merkel cell carcinoma

Autor: Joshua Veatch, Kelly Paulson, Yuta Asano, Lauren Martin, Bo Lee, Evan Thomas Hall, Shailender Bhatia, Paul Nghiem, Aude Chapuis

Publikováno v: Journal of Clinical Oncology. 40:9549-9549

9549 Background: Merkel cell carcinoma is an aggressive neuroendocrine tumor of skin origin with most cases caused by the Merkel polyoma virus (MCPyV). While many patients benefit from PD-1/PD-L1 axis blockade, most patients do not respond or develop

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0b1dc2565bcf566bd857d05d52e61fbe
https://doi.org/10.1200/jco.2022.40.16_suppl.9549

Zobrazit plný text záznamu